A STAT4 variant increases liver fibrosis risk in Caucasian patients with chronic hepatitis B.

Saved in:
Bibliographic Details
Title: A STAT4 variant increases liver fibrosis risk in Caucasian patients with chronic hepatitis B.
Authors: El Sharkawy, R.1, Thabet, K.1,2, Lampertico, P.3, Petta, S.4, Mangia, A.5, Berg, T.6, Metwally, M.1, Bayoumi, A.1, Boonstra, A.7, Brouwer, W. P.7, Smedile, A.8, Abate, M. L.8, Loglio, A.3, Douglas, M. W.1, Khan, A.1, Santoro, R.5, Fischer, J.6, Leeming, D. J.9, Liddle, C.1, George, J.1 jacob.george@sydney.edu.au
Source: Alimentary Pharmacology & Therapeutics. Sep2018, Vol. 48 Issue 5, p564-573. 10p. 1 Diagram, 1 Chart, 4 Graphs.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:02692813
DOI:10.1111/apt.14866